Transcutaneous Laryngeal Ultrasound as an Alternative to Direct Flexible Laryngoscopy in Assessment of Vocal Cords
Launched by ASSIUT UNIVERSITY · Dec 5, 2023
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of a special type of ultrasound, called transcutaneous laryngeal ultrasound, to see if it can effectively assess vocal cords instead of the traditional method known as direct flexible laryngoscopy. This trial aims to find out if ultrasound is a good alternative for checking the health of vocal cords, particularly in patients who are having thyroid surgery.
To participate in the trial, you need to be someone who is scheduled for thyroid surgery or has already undergone thyroid surgery. However, if you have vocal cord paralysis due to reasons other than complications from thyroid surgery, you will not be eligible to join. If you participate, you can expect to undergo the ultrasound assessment as part of the study, which will help researchers determine how effective this new method is compared to the standard approach. It's important to note that the trial is not yet recruiting participants, so more information will be available once it begins.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients scheduled for thyroid surgery
- • Patients underwent thyroid surgery
- Exclusion Criteria:
- • • Patients with vocal cord paralysis because of any cause other than thyroid surgery complications
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Amr Farouk, Professor
Principal Investigator
Supervisor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported